2927.T
AFC-HD AMS Life Science Co.,Ltd.
スタンダード · 食料品 · 食品 · JP
JPY 866.00
−0.35%Year over year
Reported trailing growth
- Revenue
- +2.0%
- EBITDA
- —
- EBIT
- +8.2%
- EPS
- -9.2%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- +3.8%
- EBITDA
- —
- EPS
- +10.1%
Three-year CAGR
- Revenue
- +12.4%
- EBITDA
- +23.3%
- EBIT
- +33.6%
- Net income
- +25.4%
- EPS
- +25.3%
- Free cash flow
- +6.1%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Feb 1, 2026